Fluticasone Furoate
Showing 1 - 25 of 648
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate (low dose), Vilanterol and Fluticasone Furoate
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate (low dose)
- +2 more
-
Copenhagen, DK, DenmarkAugust Krogh Building
Sep 27, 2023
Exercise Performance Trial in Copenhagen (Vilanterol and Fluticasone Furoate, Indacaterol and Mometasone Furoate, Placebo)
Recruiting
- Exercise Performance
- Vilanterol and Fluticasone Furoate
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Oct 4, 2023
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- (no location specified)
Sep 7, 2022
Using US Medical and Pharmacy Claim Records to Compare Resource
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
Eden Prairie, MinnesotaOptum
Mar 11, 2022
COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)
Completed
- COPD
- Fluticasone Furoate/Vilanterol 100/25 mcgs
- Umeclidinium/Vilanterol 62.5/25 mcgs
-
Mexico City, Tlalpan, MexicoNational Institute of Respiratory Diseases 'Ismael CosÃo Villega
Apr 18, 2022
Allergic Rhinitis Trial (Montelukast Oral Tablet)
Not yet recruiting
- Allergic Rhinitis
- Montelukast Oral Tablet
- (no location specified)
May 14, 2022
To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy, To
Recruiting
- To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy
- To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results
- Montelukast
- Fluticasone Furoate
-
Be'er Ya'aqov, IsraelAssaf-Harofeh Medical Center
Dec 7, 2022
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- ELLIPTA
- (no location specified)
Aug 15, 2022
Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,
Completed
- Asthma
- mometasone furoate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Asthma Trial (mometasone furoate dry powder inhaler, fluticasone propionate hydrofluoroalkane (HFA), montelukast)
Completed
- Asthma
- mometasone furoate dry powder inhaler
- +2 more
- (no location specified)
Feb 7, 2022
Montelukast, Chronic Rhinosinusitis With Nasal Polyps Trial in Assiut (Montelukast, Prednisolone, Fluticasone Furoate)
Active, not recruiting
- Montelukast
- Chronic Rhinosinusitis With Nasal Polyps
- Montelukast
- +2 more
-
Assiut, EgyptAssiut University Hospital
Mar 6, 2022
COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- BDP/FF/GB
- FlF/VI + Tiotropium
-
Godollo, HungaryErzsebet Gondozohaz
Oct 28, 2021
Perennial Allergic Rhinitis Trial (Placebo for MF, Placebo for FP, Mometasone)
Completed
- Perennial Allergic Rhinitis
- Placebo for MF
- +3 more
- (no location specified)
Feb 7, 2022
Replication of the IMPACT COPD Trial in Healthcare Claims Data
Completed
- COPD
- Fluticasone Furoate-Vilanterol Trifenatate
- Furoate-umeclidinium-vilanterol
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 20, 2021
Asthma in Children Trial in Haifa (Fluticasone furoate (FF)/Vilanterol (VI), Salbutamol)
Completed
- Asthma in Children
- Fluticasone furoate (FF)/Vilanterol (VI)
- Salbutamol
-
Haifa, IsraelRambam Medical Center
Feb 10, 2021
Pharmacokinetics Trial in Copenhagen (Fluticasone Furoate/ Vilanterol Trifenatate)
Completed
- Pharmacokinetics
- Fluticasone Furoate/ Vilanterol Trifenatate
-
Copenhagen, DenmarkRespiratory research unit, Bispebjerg University Hospital
Jan 26, 2021
COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol
Withdrawn
- COPD
- Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
- Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
- (no location specified)
Jan 19, 2022
Rhinitis, Allergic, Seasonal Trial in United States (Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals),
Completed
- Rhinitis, Allergic, Seasonal
- Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)
- +2 more
-
Austin, Texas
- +6 more
Jan 14, 2021
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
US Based on Pharmacy and Medical Claims That Compares How Well
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
White Plains, New YorkeMax health
Jan 11, 2022
Allergic Rhinitis Trial (Mometasone Furoate Nasal Spray, fluticasone nasal spray)
Completed
- Allergic Rhinitis
- Mometasone Furoate Nasal Spray
- fluticasone nasal spray
- (no location specified)
Feb 7, 2022
Allergic Rhinitis Trial (Mometasone Furoate Nasal Spray, fluticasone nasal spray)
Completed
- Allergic Rhinitis
- Mometasone Furoate Nasal Spray
- fluticasone nasal spray
- (no location specified)
Feb 7, 2022
Asthma in Children Trial in Cincinnati (Cholecalciferol, antihistamine, Azithromycin)
Completed
- Asthma in Children
- Cholecalciferol
- +5 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 28, 2021